Interaction of a DNA-threading netropsin - amsacrine combilexin with DNA and chromatin

Biochemistry

Volumn 35, Issue 14, 1996, Pages 4251-4264

  Bourdouxhe Housiaux, Catherine ^a   Colson, Pierre ^a   Houssier, Claude ^a   Waring, Michael J ^b   Bailly, Christian ^c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Institut de Recherche sur le Cancer de Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CONGOCIDINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CHROMATOPHORE; DNA SEQUENCE; DRUG DNA INTERACTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL;

AMSACRINE; ANIMALS; BASE SEQUENCE; BINDING SITES; CATTLE; CHROMATIN; CIRCULAR DICHROISM; DNA; DNA ADDUCTS; DRUG DESIGN; INTERCALATING AGENTS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NETROPSIN; NUCLEIC ACID CONFORMATION;

EID: 5244233576     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi9528098     Document Type: Article

References (78)

1. Abu-Daya, A., Brown, P. M., & Fox, K. R. (1995) Nucleic Acids Res. 23, 3385-3392.
2. Baguley, B. C., Denny, W. A., Atwell, G. J., & Cain, B. F. (1981) J. Med. Chem. 24, 170-177.
3. Bailly, C., & Hénichart, J. P. (1991) Bioconjugate Chem. 2, 379-393.
4. Bailly, C., & Hénichart, J. P. (1994) in Molecular Aspects of Anticancer Drug-DNA Interactions (Neidle, S., & Waring, M. J., Eds) Vol. 2, pp 162-196, Macmillan, London.
5. Bailly, C., & Waring, M. J. (1995a) J. Biomol. Struct. Dyn. 12, 869-898.
6. Bailly, C., & Waring, M. J. (1995b) Nucleic Acids Res. 23, 885-892.
7. Bailly, C., & Waring, M. J. (1995c) J. Am. Chem. Soc. 117, 7311-7316.
8. Bailly, C., Pommery, N., Houssin, R., & Hénichart, J. P. (1989) J. Pharm. Sci. 78, 910-917.
9. Bailly, C., Helbecque, N., Hénichart, J. P., Colson, P., Houssier, C., Rao, K. E., Shea, R. G., & Lown, J. W. (1990) J. Mol. Recognit. 3, 26-35.
10. Bailly, C., Collyn-d'Hooghe, M., Lantoine, D., Fournier, C., Hecquet, B., Fossé, P., Saucier, J. M., Colson, P., Houssier, C., & Hénichart, J. P. (1992a) Biochem. Pharmacol. 43, 457-466.
11. Bailly, C., OhUigin, C., Houssin, R., Colson, P., Houssier, C., Rivalle, C., Bisagni, E., Hénichart, J. P., & Waring, M. J. (1992b) Mol. Pharmacol. 41, 845-855.
12. Bailly, C., Denny, W. A., Mellor, L., Wakelin, L. P. G., & Waring, M. J. (1992c) Biochemistry 31, 3514-3524.
13. Bailly, C., Hénichart, J. P., Colson, P., & Houssier, C. (1992d) J. Mol. Recognit. 5, 155-171.
14. Bailly, C., Leclère, V., Pommery, N., Colson, P., Houssier, C., Rivalle, C., Bisagni, E., & Hénichart, J. P. (1993) Anti-Cancer Drug Des. 8, 145-164.
15. Bailly, C., Michaux, C., Colson, P., Houssier, C., Sun, J. S., Garestier, T., Hélène, C., Hénichart, J. P., Rivalle, C., Bisagni, E., & Waring, M. J. (1994) Biochemistry 33, 15348-15364.
16. Bartkowiak, J., Kapuscinski, J., Melamed, M. R., &, Darzynkiewicz, Z. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 5151-5154.
17. Bishop, J. M. (1987) Science 235, 305-311.
18. Bourdouxhe, C., Colson, P., Houssier, C., Sun, J.-S., Montenay-Garestier, T., Hélène, C., Rivalle, C., Bisagni, E., Waring, M. J., Hénichart, J. P., & Bailly, C. (1992) Biochemistry 31, 12385-12396.
19. Bourdouxhe, C., Colson, P., Houssier, C., Hénichart, J. P., Waring, M. J., Denny, W. A., & Bailly, C. (1995) Anti-Cancer Drug Des. 10, 131-154.
20. Chaires, J. B. (1990) Biophys. Chem. 35, 191-202.
21. Chaires, J. B., Dattagupta, N., & Crothers, D. M. (1985) Biochemistry 24, 260-267.
22. Chen, A. Y., & Liu, L. F. (1994) Annu. Rev. Pharmacol. Toxicol. 34, 191-218.
23. Chen, Y.-H., & Lown, J. W. (1994) J. Am. Chem. Soc. 116, 6995-7005.
24. Clark, D., Reitman, M., Studitsky, V., Chung, J., Westphal, H., Lee, E., & Felsenfeld, G. (1993) Cold Spring Harbor Symp. Quant. Biol. 58, 1-6.
25. Colson, P., Bailly, C., & Houssier, C. (1996) Biophys. Chem. 58, 125-140.
26. Denny, W. A., & Wakelin, L. P. G. (1986) Cancer Res. 46, 1717-1721.
27. Denny, W. A., & Wakelin, L. P. G. (1990) Anti-Cancer Drug Des. 5, 189-200.
28. Egli, M., Williams, L. D., Frederick, C. A., & Rich, A. (1991) Biochemistry 30, 1364-1372.
29. Feigon, J., Denny, W. A., Leupin, W., & Kearns, D. R. (1984) J. Med. Chem. 27, 450-465.
30. Felsenfeld, G. (1992) Nature 355, 219-224.
31. Fossé, P., René, B., Saucier, J. M., Hénichart, J. P., Waring, M. J., Colson, P., Houssier, C., & Bailly, C. (1994) Biochemistry 33, 9865-9874.
32. Geierstanger, B. H., Mrksich, M., Dervan, P. B., & Wemmer, D. E. (1994) Science 266, 646-650.
33. Hagmar, P., Marquet, R., Colson, P., Kubista, M., Nielsen, P., Nordèn, B., & Houssier, C. (1989) J. Biomol. Struct. Dyn. 7, 19-33.
34. Hagmar, P., Pierrou, S., Nielsen, P., Nordén, B., & Kubista, M. (1992) J. Biomol. Struct. Dyn. 9, 667-679.
35. Hansen, J. C., & Ausio, J. (1992) Trends Biochem. Sci. 17, 187-191.
36. Hansen, M., & Hurley, L. (1995) J. Am. Chem. Soc. 117, 2421-2429.
37. Hansen, M., Yun, S., & Hurley, L. H. (1995) Chem. Biol. 2, 229-240.
38. Houssier, C. (1981) in Molecular Electro-Optics (Krause, S., Ed.) pp 363-398, Plenum Publishing Corp., New York.
39. Houssier, C., & O'Konski, C. T. (1981) in Molecular Electro-Optics (Krause, S., Ed.) pp 309-339, Plenum Publishing Corp., New York.
40. Hurley, L. H. (1988) Trends Pharmacol. Sci. 9, 402-407.
41. Hurley, L. H. (1989) J. Med. Chem. 32, 2027-2033.
42. Kapuscinski, J., & Darzynkiewicz, Z. (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 7368-7372.
43. Kapuscinski, J., & Darzynkiewicz, Z. (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 6302-6306.
44. Kim, S. K., Eriksson, S., Kubista, M., & Norden, B. (1993) J. Am. Chem. Soc. 115, 3441-3447.
45. Kopka, M. L., & Larsen, T. A. (1992) in Nucleic Acid Targeted Drug Design (Propst, C. L., & Perun, T. J., Eds.) pp 303-374, Marcel Dekker, Inc., New York.
46. Low, C. M. L., Drew, H. R., & Waring, M. J. (1984) Nucleic Acids Res. 12, 4865-4877.
47. Lown, J. W. (1995) Drug Dev. Res. 34, 145-183.
48. Lyng, R., Rodger, A., & Nordén, B. (1991) Biopolymers 31, 1709-1720.
49. Lyng, R., Rodger, A., & Norden, B. (1992) Biopolymers 31, 1201-1214.
50. McConnaughie, A. W., & Jenkins, T. C. (1995) J. Med. Chem. 38, 3488-3501.
51. Müller, W., & Crothers, D. M. (1968) J. Mol. Biol. 35, 251-290.
52. Nielsen, P. E. (1991) Bioconjugate Chem. 2, 1-12.
53. Plouvier, B., Houssin, R., Hecquet, B., Colson, P., Houssier, C., Waring, M. J., Henichart, J. P., & Bailly, C. (1994) Bioconjugate Chem. 5, 475-481.
54. Pohl, F. M., & Jovin, T. (1972) J. Mol. Biol. 67, 375-396.
55. Portugal, J., & Waring, M. J. (1987) Eur. J. Biochem. 167, 281-289.
56. Powis, G., & Workman, P. (1994) Anti-Cancer Drug Des. 9, 263-277.
57. Ralph, R. K., Judd, W., Pommier, Y., & Kohn, K. W. (1993) in Molecular Aspects of Anticancer Drug-DNA Interactions (Neidle, S., & Waring, M. J., Eds.) pp 1-95, Macmillan, London.
58. René, B., Fossé, P., Khélifa, T., Jacquemin-Sablin, A., & Bailly, C. (1996) Mol. Pharmacol. (in press).
59. Revet, B. M., Schmir, M., & Vinograd, J. (1971) Nat. New Biol. 229, 10-13.
60. Riou, J. F., Grondard, L., Naudin, A., & Bailly, C. (1995) Biochem. Pharmacol. 50, 424-428.
61. Schröter, H., Maier, G., Ponsting, H., & Nordheim, A. (1985) EMBO J. 4, 3867-3872.
62. Smith, C. K., Davies, G. J., Dodson, E. J., & Moore, M. H. (1995) Biochemistry 34, 415-425.
63. Snounou, G., & Malcolm, A. D. B. (1983) J. Mol. Biol. 167, 211-216.
64. Sun, D., Hansen, M., & Hurley, L. H. (1995) J. Am. Chem. Soc. 117, 2430-2440.
65. Tanious, F. A., Jenkins, T. C., Neidle, S., & Wilson, W. D. (1992) Biochemistry 31, 11632-11640.
66. Triebel, H., Bär, H., Walter, A., Burckhardt, G., & Zimmer, Ch. (1994) J. Biomol. Struct. Dyn. 11, 1085-1105.
67. Van de Sande, J. H., & Jovin, T. M. (1982) EMBO J. 1, 115-126.
68. van Houte, L. P. A., van Garderen, C. J., & Patel, D. J. (1993) Biochemistry 32, 1667-1674.
69. Wakelin, L. P. G., & Waring, M. J. (1980) J. Mol. Biol. 144, 183-214.
70. Wakelin, L. P. G., Chetcuti, P., & Denny, W. A. (1990) J. Med. Chem. 33, 2039-2044.
71. Wang, J. C. (1974) J. Mol. Biol. 89, 783-801.
72. Waring, M. J. (1970) J. Mol. Biol. 54, 247-279.
73. Waring, M. J. (1976) Eur. J. Cancer 12, 995-1001.
74. Waring, M. J., & Henley, S. M. (1975) Nucleic Acids Res. 2, 567-586.
75. Wells, R. D., Larson, J. E., Grant, R. C., Shortle, B. E., & Cantor, C. R. (1970) J. Mol. Biol. 54, 465-497.
76. Wilson, W. D., & Tanious, F. A. (1994) in Molecular Aspects of Anticancer Drug-DNA Interactions (Neidle, S., & Waring, M. J., Eds.) Vol. 2, pp 243-269, Macmillan, London.
77. Wolffe, A. (1992) Chromatin. Structure and Function, Academic Press, London.
78. Zimmer, C., Marck, C., Guschlbauer, W. (1983) FEBS Lett. 154, 156-160.